The Cost-Effectiveness of Early High-Acuity Postoperative Care for Medium-Risk Surgical Patients

被引:1
|
作者
Leaman, Esrom E. [1 ,2 ]
Ludbrook, Guy L. [1 ,2 ]
机构
[1] Royal Adelaide Hosp, Dept Anaesthesia, 3G 395,1 N Terr, Adelaide 5000, Australia
[2] Univ Adelaide, Discipline Acute Care Med, Adelaide, Australia
来源
ANESTHESIA AND ANALGESIA | 2024年 / 139卷 / 02期
关键词
SURGERY; MORTALITY; LENGTH; STAY;
D O I
10.1213/ANE.0000000000006743
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND:Initiatives in perioperative care warrant robust cost-effectiveness analysis in a cost-constrained era when high-value care is a priority. A model of anesthesia-led early high-acuity postoperative care, advanced recovery room care (ARRC), has shown benefit in terms of hospital and patient outcomes, but its cost-effectiveness has not yet been formally determined.METHODS:Data from a previously published single-center prospective cohort study of ARRC in medium-risk patients were used to generate a Markov model, which described patient transition between care locations, each with different characteristics and costs. The incremental cost-effectiveness ratio (ICER), using days at home (DAH) and hospital costs, was calculated for ARRC compared to usual ward care using deterministic and probabilistic sensitivity analysis.RESULTS:The Markov model accurately described patient disposition after surgery. For each patient, ARRC provided 4.3 more DAH within the first 90 days after surgery and decreased overall hospital costs by $1081 per patient. Probabilistic sensitivity analysis revealed that ARRC had a 99.3% probability of increased DAH and a 77.4% probability that ARRC was dominant from the perspective of the hospital, with improved outcomes and decreased costs.CONCLUSIONS:Early high-acuity care for approximately 24 hours after surgery in medium-risk patients provides highly cost-effective improvements in outcomes when compared to usual ward care.
引用
下载
收藏
页码:323 / 331
页数:9
相关论文
共 50 条
  • [21] Preoperative and postoperative care of standard and high risk surgical patients
    Reilly, JJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (03) : 449 - &
  • [22] HIGH-QUALITY CARE OR COST-EFFECTIVENESS
    LUCE, PJ
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1995, 49 (01): : 5 - 5
  • [23] Cost-effectiveness of evolocumab in patients with high atherosclerotic cardiovascular risk in Sweden
    Lindgren, P.
    Hagstrom, E.
    Van Hout, B.
    Villa, G.
    Urbich, M.
    Sandelin, R.
    Svensson, M. Eriksson
    Fonarow, G. C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 681 - 681
  • [24] Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Hemery, Francois
    Kuentz, Mathieu
    Cordonnier, Catherine
    BLOOD, 2008, 112 (11) : 475 - 475
  • [25] Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
    Shuli Qu
    Xuedan You
    Tianyi Liu
    Lijiao Wang
    Zheng Yin
    Yanjun Liu
    Chong Ye
    Ting Yang
    Mao Huang
    Hongchao Li
    Liwen Fang
    Jinping Zheng
    npj Primary Care Respiratory Medicine, 31
  • [26] Cost-effectiveness of antifungal strategies in high-risk neutropenic patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Kuentz, Mathieu
    Cordonnier, Catherine
    BLOOD, 2007, 110 (11) : 153B - 153B
  • [27] COST-EFFECTIVENESS OF TICLOPIDINE IN PREVENTING STROKE IN HIGH-RISK PATIENTS
    OSTER, G
    HUSE, DM
    LACEY, MJ
    EPSTEIN, AM
    STROKE, 1994, 25 (06) : 1149 - 1156
  • [28] Safety and cost-effectiveness of MIDCABG in high-risk CABG patients
    Del Rizzo, DF
    Boyd, WD
    Novick, RJ
    McKenzie, FN
    Desai, ND
    Menkis, AH
    ANNALS OF THORACIC SURGERY, 1998, 66 (03): : 1002 - 1007
  • [29] SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF PALIVIZUMAB IN HIGH-RISK PATIENTS
    Paladio Duran, N.
    Garcia-Altes, A.
    Pons Rafols, J. M.
    Tebe Cordomi, C.
    VALUE IN HEALTH, 2009, 12 (07) : A432 - A432
  • [30] Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
    Qu, Shuli
    You, Xuedan
    Liu, Tianyi
    Wang, Lijiao
    Yin, Zheng
    Liu, Yanjun
    Ye, Chong
    Yang, Ting
    Huang, Mao
    Li, Hongchao
    Fang, Liwen
    Zheng, Jinping
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2021, 31 (01)